Le Lézard
Classified in: Health, Science and technology
Subjects: AWD, SCZ, SBS, AVO, FVT

Finalists announced in national competition to identify healthy aging solutions


TORONTO, Sept. 6, 2018 /CNW/ - It started as a challenge to Canadians to come up with great new ideas to support healthy aging. The AGE-WELL National Impact Challenge triggered a flood of submissions. After a round of public voting, AGE-WELL is pleased to announce the finalists.

Eight finalists will compete for over $100,000 in cash and in-kind prizes at a live pitch event in Vancouver, British Columbia, where they will showcase how their solution could positively impact older Canadians or their caregivers.

The finalists are:  

"The depth and diversity of the ideas is impressive," says Dr. Alex Mihailidis, Scientific Director of AGE-WELL, Canada's Technology and Aging Network, which is hosting the competition. "A lot of creative thinking has gone into developing these proposed solutions."

The AGE-WELL National Impact Challenge aims to identify great new ideas for technology-based solutions that will improve the quality of life of older Canadians and/or their caregivers.

The challenge drew 60 video submissions from Canadians. Almost 15,000 votes were cast by members of the public during online voting between August 1 and August 17, 2018. The list of finalists includes the contestant who received the most votes in each of four geographic zones (a fifth zone did not receive entries).

In addition to the four contestants chosen from the zones, three wild card videos were selected to participate in the finale: Young Innovator (chosen by AGE-WELL's Education and Training Program Leads), Stakeholder Favourite (chosen by a member of AGE-WELL's Older Adult and Caregiver Advisory Committee) and Most Mentioned (video with the most social media activity and mentions), plus the winning team from the AGE-WELL 2018 Summer Institute.

The grand finale will be held on October 17, 2018 at the AGE-WELL Annual Conference in Vancouver. Each finalist will give a five-minute presentation to a panel of expert judges.

The cash prize associated with the competition is to be used solely for research and development of the submitted idea, its dissemination or commercialization. For more about the finalists, prize details, and competition terms and conditions, please visit the competition main page.

Generous sponsors of the AGE-WELL National Impact Challenge are: Bereskin & Parr, CARP, the Impact Centre, Revera, Sun Life Financial, and TELUS Ventures.

Register here to attend AGE-WELL's 4th Annual Conference on October 16-18, 2018 at the Sheraton Vancouver Wall Centre.

About AGE-WELL:

AGE-WELL NCE Inc. (http://www.agewell-nce.ca/@AGEWELL_NCE) is Canada's Technology and Aging Network. AGE-WELL brings together researchers, older adults, caregivers, partner organizations and future leaders to accelerate the delivery of technology-based solutions that make a meaningful difference in the lives of Canadians. AGE-WELL researchers are producing technologies, services and policies/practices to improve quality of life for older adults and caregivers, and generate social and economic benefits for Canada. AGE-WELL was launched in 2015 through the federally-funded Networks of Centres of Excellence (NCE) program.

SOURCE AGE-WELL Network of Centres of Excellence (NCE)


These press releases may also interest you

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
ICEYE, a global leader in satellite-powered disaster management solutions, has announced a new data collaboration with Juniper Re, LLC ("Juniper Re"), the dynamic reinsurance broking arm and indirect subsidiary of BRP Group, Inc. . Juniper Re will...

at 02:00
CACI is delighted to announce that its Cygnum software will be used by the Environment Agency as a logistics planning tool to schedule its workforce and assets in the preparation of and response to incidents across England ranging from small...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...

at 01:38
The Barcelona R&D Center ("the Center") of Wanhua Chemical (SHA:600309; "the Company"), located at Cornella de Llobregat, has officially opened its doors as a pivotal move by the company to advance its footprint in Europe and beyond with a quicker...



News published on and distributed by: